Skip to main content
European Commission logo print header

A novel pharmaceutical treatment for nonalcoholic fatty liver disease

Publications

miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression

Author(s): Geula Hanin, Nadav Yayon, Yonat Tzur, Rotem Haviv, Estelle R Bennett, Shiran Udi, Yoganathan R Krishnamoorthy, Eleni Kotsiliti, Rivka Zangen, Ben Efron, Joseph Tam, Orit Pappo, Eyal Shteyer, Eli Pikarsky, Mathias Heikenwalder, David S Greenberg, Hermona Soreq
Published in: Gut, Issue 67/6, 2018, Page(s) 1124-1134, ISSN 0017-5749
Publisher: BMJ Publishing Group
DOI: 10.1136/gutjnl-2016-312869

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available